Home > Keywords > Thématique > Prix

Prix

Articles

  • Vect-Horus has been honored with a prestigious European Enterprise Award
    18 March, by Emmanuelle BETTENDORF

    We are thrilled to announce that Vect-Horus has been honored with a prestigious European Enterprise Award by EU Business News! Vect-Horus is cited as one of the Pharma & Biotech Innovators of the Year 2024 ».
    These awards recognize outstanding businesses thriving across Europe. This recognition highlights our ongoing commitment to innovation in biotechnology, particularly our efforts to revolutionize drug delivery using our unique VECTrans® technology.
    A heartfelt thank you to our (…)

  • Vect-Horus: Top Drug Discovery and Development Europe Companies
    2 April 2020, by Elodie DORMES

    Vect-Horus: Innovation to "Bypass" the Barriers
    PharmaTechOutlook elected Vect-Horus as one of the ten companies that are at the forefront of providing Drug Discovery and Development solutions and transforming businesses in Europe in 2020.
    Full article accessible at https://drug-discovery-and-development-europe.pharmatechoutlook.com/vendor/vecthorus-innovation-to—bypass—the-barriers-cid-724-mid-77.html

  • Vect-Horus one the 50 Best Companies to Watch 2020 according to the Silicon Review magazine
    10 August 2020, by Elodie DORMES

    A pioneer in drug delivery with an innovative targeting technology: Vect-Horus
    Full article available at: https://thesiliconreview.com/magazine/profile/vect-horus-innovative-targeting-technology/

  • Vect-Horus rejoint la communauté Bpifrance Excellence
    28 January 2019, by Jonathan NOWAK

    L’entrée de la société de « CNS Drug Delivery » dans le cercle très fermé des membres de Bpifrance Excellence récompense l’innovation apportée par sa plateforme VECTrans®

  • Vect-Horus is one of the CNRS 15 success stories
    28 January 2019, by Jonathan NOWAK

    VECT-HORUS was recently identified by the CNRS as one of the 15 success stories in 1,000 companies created from CNRS laboratories.

  • VECT-HORUS recognized as a newcomer to the theranostic field by Labiotech
    12 November 2020, by Elodie DORMES

    Vect-Horus mentioned as a relative newcomer to the theranostic field with a high potential in “Radiopharmaceuticals Gain Traction for Cancer Theranostics Potential” article by Labiotech - Europe’s Leading Biotech news website.
    Full article available at https://www.labiotech.eu/cancer/theranostics-radiopharmaceuticals-nuclear-medicine/

  • Gerhard Levy Distinguished Lectureship in Pharmaceutical Sciences for Prof. Scherrmann, chairman of Vect-Horus’ Scientific Advisory Board
    28 January 2019, by Jonathan NOWAK

    University at Buffalo, The State University of New York distinguished Professor Emeritus of Pharmaceutical Sciences Gerhard Levy was a pioneer and leading contributor in the areas of pharmacokinetics and clinical pharmacokinetics.
    The Gerhard Levy Lecture Series is held annually in recognition of the significant contributions Levy made in his fields of study and to honor a beloved friend and esteemed colleague who deftly balanced his love of teaching with robust research.
    2017 guest (…)

  • Vect-Horus receives the Frost & Sullivan 2016 Leadership award
    28 January 2019, by Jonathan NOWAK

    Press release
    Communiqué de presse
    French biotechnology startup VECT-HORUS, a European leader in the design of vectors that facilitate the delivery of drugs into the brain and other organs, receives the Frost & Sullivan 2016 Leadership award for its VECTrans® innovative technology.
    Vect-Horus sur France 3